Abstract
Emerging evidences have implicated extracellular vesicles (EVs), nanoparticles secreted by cells, in regulating cancer progression. Several seminal studies on EVs have added an additional layer to the previously unanswered questions in understanding the complexity of diseases such as cancer. It has been observed that EV content is highly heterogenous and it likely reflects the dynamic state of the parent cell. Hence, these nano-sized vesicles have been proposed as reservoirs of cancer biomarkers for diagnostic and prognostic purposes. Due to their presence in almost all biological fluids, ability to display membrane, and sometimes cytosolic, cargo of its host cell and increase in their number during disease states has supported the potential utility of EVs as an alternative to current methods of cancer diagnosis. The following chapter will discuss the use of cancer cell-derived EVs as a resource of tumor specific biomarkers for the early diagnosis of disease. In addition, EVs could also be used in personalised medicine as a resource of predictive biomarkers to understand a patient’s response to therapy. Overall, EVs could be exploited as a source of cancer biomarkers and could aid in treatment and stratification options to improve patient survival and quality of life.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769):503–511. https://doi.org/10.1038/35000501
Armacki M, Polaschek S, Waldenmaier M, Morawe M, Ruhland C, Schmid R, Lechel A, Tharehalli U, Steup C, Bektas Y, Li H, Kraus JM, Kestler HA, Kruger S, Ormanns S, Walther P, Eiseler T, Seufferlein T (2020) Protein kinase D1, reduced in human pancreatic tumors, increases secretion of small extracellular vesicles from cancer cells that promote metastasis to lung in mice. Gastroenterology. https://doi.org/10.1053/j.gastro.2020.05.052
Au Yeung CL, Co NN, Tsuruga T, Yeung TL, Kwan SY, Leung CS, Li Y, Lu ES, Kwan K, Wong KK, Schmandt R, Lu KH, Mok SC (2016) Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1. Nat Commun 7:11150. https://doi.org/10.1038/ncomms11150
Ballehaninna UK, Chamberlain RS (2011) Serum CA 19-9 as a biomarker for pancreatic cancer: a comprehensive review. Indian J Surg Oncol 2(2):88–100. https://doi.org/10.1007/s13193-011-0042-1
Bandari SK, Purushothaman A, Ramani VC, Brinkley GJ, Chandrashekar DS, Varambally S, Mobley JA, Zhang Y, Brown EE, Vlodavsky I, Sanderson RD (2018) Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol 65:104–118. https://doi.org/10.1016/j.matbio.2017.09.001
Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR Jr, Knapp RC (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309(15):883–887. https://doi.org/10.1056/NEJM198310133091503
Beltran H, Eng K, Mosquera JM, Sigaras A, Romanel A, Rennert H, Kossai M, Pauli C, Faltas B, Fontugne J, Park K, Banfelder J, Prandi D, Madhukar N, Zhang T, Padilla J, Greco N, McNary TJ, Herrscher E, Wilkes D, MacDonald TY, Xue H, Vacic V, Emde AK, Oschwald D, Tan AY, Chen Z, Collins C, Gleave ME, Wang Y, Chakravarty D, Schiffman M, Kim R, Campagne F, Robinson BD, Nanus DM, Tagawa ST, Xiang JZ, Smogorzewska A, Demichelis F, Rickman DS, Sboner A, Elemento O, Rubin MA (2015) Whole-exome sequencing of metastatic cancer and biomarkers of treatment response. JAMA Oncol 1(4):466–474. https://doi.org/10.1001/jamaoncol.2015.1313
Bennett MR, Devarajan P (2011) Chapter 1 - Characteristics of an ideal biomarker of kidney diseases. In: Edelstein CL (ed) Biomarkers of kidney disease. Academic Press, San Diego, pp 1–24. https://doi.org/10.1016/B978-0-12-375672-5.10001-5
Biomarkers Definitions Working G (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95. https://doi.org/10.1067/mcp.2001.113989
Bouanene H, Miled A (2009) Tumor marker CA125: biochemical and molecular properties. Bull Cancer 96(5):597–601. https://doi.org/10.1684/bdc.2009.0859
Boukouris S, Mathivanan S (2015) Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin Appl 9(3–4):358–367. https://doi.org/10.1002/prca.201400114
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492
Brofelth M, Ekstrand AI, Gour S, Jansson R, Hedhammar M, Elleby B, Kvist A, Wingren C, Axelsson U, Borrebaeck CAK (2020) Multiplex profiling of serum proteins in solution using barcoded antibody fragments and next generation sequencing. Commun Biol 3(1):339. https://doi.org/10.1038/s42003-020-1068-0
Buzas EI, Gyorgy B, Nagy G, Falus A, Gay S (2014) Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol 10(6):356–364. https://doi.org/10.1038/nrrheum.2014.19
Carollo E, Paris B, Samuel P, Pantazi P, Bartelli TF, Dias-Neto E, Brooks SA, Pink RC, Carter DRF (2019) Detecting ovarian cancer using extracellular vesicles: progress and possibilities. Biochem Soc Trans 47(1):295–304. https://doi.org/10.1042/BST20180286
Castillo J, Bernard V, San Lucas FA, Allenson K, Capello M, Kim DU, Gascoyne P, Mulu FC, Stephens BM, Huang J, Wang H, Momin AA, Jacamo RO, Katz M, Wolff R, Javle M, Varadhachary G, Wistuba II, Hanash S, Maitra A, Alvarez H (2018) Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Ann Oncol 29(1):223–229. https://doi.org/10.1093/annonc/mdx542
Chen IH, Xue L, Hsu CC, Paez JS, Pan L, Andaluz H, Wendt MK, Iliuk AB, Zhu JK, Tao WA (2017) Phosphoproteins in extracellular vesicles as candidate markers for breast cancer. Proc Natl Acad Sci USA 114(12):3175–3180. https://doi.org/10.1073/pnas.1618088114
Chitti SV, Fonseka P, Mathivanan S (2018) Emerging role of extracellular vesicles in mediating cancer cachexia. Biochem Soc Trans 46(5):1129–1136. https://doi.org/10.1042/BST20180213
Cho HJ, Eun JW, Baek GO, Seo CW, Ahn HR, Kim SS, Cho SW, Cheong JY (2020) Serum exosomal MicroRNA, miR-10b-5p, as a potential diagnostic biomarker for early-stage hepatocellular carcinoma. J Clin Med 9(1). https://doi.org/10.3390/jcm9010281
Colakovic S, Lukic V, Mitrovic L, Jelic S, Susnjar S, Marinkovic J (2000) Prognostic value of CA125 kinetics and half-life in advanced ovarian cancer. Int J Biol Markers 15(2):147–152
Collins FS (1999) Shattuck lecture. Medical and societal consequences of the human genome project. N Engl J Med 341(1):28–37. https://doi.org/10.1056/NEJM199907013410106
Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, Garcia-Santos G, Williams C, Ararso Y, Huang Y, Rodrigues G, Shen TL, Labori KJ, Lothe IM, Kure EH, Hernandez J, Doussot A, Ebbesen SH, Grandgenett PM, Hollingsworth MA, Jain M, Mallya K, Batra SK, Jarnagin WR, Schwartz RE, Matei I, Peinado H, Stanger BZ, Bromberg J, Lyden D (2015) Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 17(6):816–826. https://doi.org/10.1038/ncb3169
Duffy MJ (2010) Use of biomarkers in screening for cancer. EJIFCC 21(1):1–12
Duffy MJ (2013) Tumor markers in clinical practice: a review focusing on common solid cancers. Med Princ Pract 22(1):4–11. https://doi.org/10.1159/000338393
Gangoda L, Boukouris S, Liem M, Kalra H, Mathivanan S (2015) Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic? Proteomics 15(2–3):260–271. https://doi.org/10.1002/pmic.201400234
Gould SJ, Raposo G (2013) As we wait: coping with an imperfect nomenclature for extracellular vesicles. J Extracell Vesicles 2. https://doi.org/10.3402/jev.v2i0.20389
Guescini M, Genedani S, Stocchi V, Agnati LF (2010) Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. J Neural Transm (Vienna) 117(1):1–4. https://doi.org/10.1007/s00702-009-0288-8
Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding WQ (2016) Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res 18(1):90. https://doi.org/10.1186/s13058-016-0753-x
Herreros-Villanueva M, Bujanda L (2016) Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer. Ann Transl Med 4(4):64. https://doi.org/10.3978/j.issn.2305-5839.2015.10.39
Hoffman JA, Papas BN, Trotter KW, Archer TK (2020) Single-cell RNA sequencing reveals a heterogeneous response to glucocorticoids in breast cancer cells. Commun Biol 3(1):126. https://doi.org/10.1038/s42003-020-0837-0
Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Zhang T, Zhang H, Hernandez J, Weiss JM, Dumont-Cole VD, Kramer K, Wexler LH, Narendran A, Schwartz GK, Healey JH, Sandstrom P, Labori KJ, Kure EH, Grandgenett PM, Hollingsworth MA, de Sousa M, Kaur S, Jain M, Mallya K, Batra SK, Jarnagin WR, Brady MS, Fodstad O, Muller V, Pantel K, Minn AJ, Bissell MJ, Garcia BA, Kang Y, Rajasekhar VK, Ghajar CM, Matei I, Peinado H, Bromberg J, Lyden D (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527(7578):329–335. https://doi.org/10.1038/nature15756
Huang SH, Li Y, Zhang J, Rong J, Ye S (2013) Epidermal growth factor receptor-containing exosomes induce tumor-specific regulatory T cells. Cancer Investig 31(5):330–335. https://doi.org/10.3109/07357907.2013.789905
Hydbring P, De Petris L, Zhang Y, Branden E, Koyi H, Novak M, Kanter L, Haag P, Hurley J, Tadigotla V, Zhu B, Skog J, Viktorsson K, Ekman S, Lewensohn R (2018) Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression. Lung Cancer 124:45–52. https://doi.org/10.1016/j.lungcan.2018.07.018
Im H, Shao H, Park YI, Peterson VM, Castro CM, Weissleder R, Lee H (2014) Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol 32(5):490–495. https://doi.org/10.1038/nbt.2886
Kalra H, Drummen GP, Mathivanan S (2016) Focus on extracellular vesicles: introducing the next small big thing. Int J Mol Sci 17(2):170. https://doi.org/10.3390/ijms17020170
Kim N, Kim HK, Lee K, Hong Y, Cho JH, Choi JW, Lee JI, Suh YL, Ku BM, Eum HH, Choi S, Choi YL, Joung JG, Park WY, Jung HA, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ, Lee HO (2020) Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun 11(1):2285. https://doi.org/10.1038/s41467-020-16164-1
Kreger BT, Johansen ER, Cerione RA, Antonyak MA (2016) The enrichment of survivin in exosomes from breast cancer cells treated with paclitaxel promotes cell survival and Chemoresistance. Cancers (Basel) 8(12). https://doi.org/10.3390/cancers8120111
Lea J, Sharma R, Yang F, Zhu H, Ward ES, Schroit AJ (2017) Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study. Oncotarget 8(9):14395–14407. https://doi.org/10.18632/oncotarget.14795
Lee CH, Im EJ, Moon PG, Baek MC (2018) Discovery of a diagnostic biomarker for colon cancer through proteomic profiling of small extracellular vesicles. BMC Cancer 18(1):1058. https://doi.org/10.1186/s12885-018-4952-y
Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ (2009) Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer 9:244. https://doi.org/10.1186/1471-2407-9-244
Makler A, Asghar W (2020) Exosomal biomarkers for cancer diagnosis and patient monitoring. Expert Rev Mol Diagn 20(4):387–400. https://doi.org/10.1080/14737159.2020.1731308
Mathivanan S (2012) Quest for cancer biomarkers: assaying mutant proteins and rna that provides the much needed specificity. J Proteomics Bioinform 5(5):xiii–xvii
Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteome 73(10):1907–1920
Mathivanan S, Ji H, Tauro BJ, Chen YS, Simpson RJ (2012) Identifying mutated proteins secreted by colon cancer cell lines using mass spectrometry. J Proteome. https://doi.org/10.1016/j.jprot.2012.06.031
Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N, Reissfelder C, Pilarsky C, Fraga MF, Piwnica-Worms D, Kalluri R (2015) Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523(7559):177–182. https://doi.org/10.1038/nature14581
Pathan M, Fonseka P, Chitti SV, Kang T, Sanwlani R, Van Deun J, Hendrix A, Mathivanan S (2019) Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Res 47(D1):D516–D519. https://doi.org/10.1093/nar/gky1029
Peng P, Yan Y, Keng S (2011) Exosomes in the ascites of ovarian cancer patients: origin and effects on anti-tumor immunity. Oncol Rep 25(3):749–762. https://doi.org/10.3892/or.2010.1119
Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH (2009) Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10(1):42–46
Rustin G, Tuxen M (1996) Use of CA 125 in follow-up of ovarian cancer. Lancet 348(9021):191–192. https://doi.org/10.1016/s0140-6736(05)66133-8
Sagar G, Sah RP, Javeed N, Dutta SK, Smyrk TC, Lau JS, Giorgadze N, Tchkonia T, Kirkland JL, Chari ST, Mukhopadhyay D (2016) Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Gut 65(7):1165–1174. https://doi.org/10.1136/gutjnl-2014-308350
Samanta S, Rajasingh S, Drosos N, Zhou Z, Dawn B, Rajasingh J (2018) Exosomes: new molecular targets of diseases. Acta Pharmacol Sin 39(4):501–513. https://doi.org/10.1038/aps.2017.162
Sandfeld-Paulsen B, Jakobsen KR, Baek R, Folkersen BH, Rasmussen TR, Meldgaard P, Varming K, Jorgensen MM, Sorensen BS (2016) Exosomal proteins as diagnostic biomarkers in lung cancer. J Thorac Oncol 11(10):1701–1710. https://doi.org/10.1016/j.jtho.2016.05.034
Sharma S, Zuniga F, Rice GE, Perrin LC, Hooper JD, Salomon C (2017) Tumor-derived exosomes in ovarian cancer - liquid biopsies for early detection and real-time monitoring of cancer progression. Oncotarget 8(61):104687–104703. https://doi.org/10.18632/oncotarget.22191
Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110(1):13–21
Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, Zheng Y, Hoshino A, Brazier H, Xiang J, Williams C, Rodriguez-Barrueco R, Silva JM, Zhang W, Hearn S, Elemento O, Paknejad N, Manova-Todorova K, Welte K, Bromberg J, Peinado H, Lyden D (2014) Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res 24(6):766–769. https://doi.org/10.1038/cr.2014.44
Ullal AV, Peterson V, Agasti SS, Tuang S, Juric D, Castro CM, Weissleder R (2014) Cancer cell profiling by barcoding allows multiplexed protein analysis in fine-needle aspirates. Sci Transl Med 6(219):219. https://doi.org/10.1126/scitranslmed.3007361
Vaksman O, Trope C, Davidson B, Reich R (2014) Exosome-derived miRNAs and ovarian carcinoma progression. Carcinogenesis 35(9):2113–2120. https://doi.org/10.1093/carcin/bgu130
Vallabhajosyula P, Korutla L, Habertheuer A, Yu M, Rostami S, Yuan CX, Reddy S, Liu C, Korutla V, Koeberlein B, Trofe-Clark J, Rickels MR, Naji A (2017) Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J Clin Invest 127(4):1375–1391. https://doi.org/10.1172/JCI87993
van Buggenum JAG, Gerlach JP, Tanis SEJ, Hogeweg M, Jansen P, Middelwijk J, van der Steen R, Vermeulen M, Stunnenberg HG, Albers CA, Mulder KW (2018) Immuno-detection by sequencing enables large-scale high-dimensional phenotyping in cells. Nat Commun 9(1):2384. https://doi.org/10.1038/s41467-018-04761-0
Weatherall D, Greenwood B, Chee HL, Wasi P (2006) Science and technology for disease control: past, present, and future. In: Jamison DT, Breman JG et al (eds) Disease control priorities in developing countries. World Bank, Washington, DC
Xue X, Zhao Y, Wang X, Qin L, Hu R (2019) Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma. J Cell Biochem 120(1):135–142. https://doi.org/10.1002/jcb.27165
Yokoi A, Yoshioka Y, Hirakawa A, Yamamoto Y, Ishikawa M, Ikeda SI, Kato T, Niimi K, Kajiyama H, Kikkawa F, Ochiya T (2017) A combination of circulating miRNAs for the early detection of ovarian cancer. Oncotarget 8(52):89811–89823. https://doi.org/10.18632/oncotarget.20688
Zhang G, Liu Z, Ding H, Zhou Y, Doan HA, Sin KWT, Zhu ZJ, Flores R, Wen Y, Gong X, Liu Q, Li YP (2017) Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90. Nat Commun 8(1):589. https://doi.org/10.1038/s41467-017-00726-x
Zhou J, Gong G, Tan H, Dai F, Zhu X, Chen Y, Wang J, Liu Y, Chen P, Wu X, Wen J (2015) Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma. Oncol Rep 33(6):2915–2923. https://doi.org/10.3892/or.2015.3937
Zijlstra A, Di Vizio D (2018) Size matters in nanoscale communication. Nat Cell Biol 20(3):228–230. https://doi.org/10.1038/s41556-018-0049-8
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chitti, S.V., Nedeva, C. (2021). Extracellular Vesicles Contain Putative Cancer Biomarkers. In: Mathivanan, S., Fonseka, P., Nedeva, C., Atukorala, I. (eds) New Frontiers: Extracellular Vesicles. Subcellular Biochemistry, vol 97. Springer, Cham. https://doi.org/10.1007/978-3-030-67171-6_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-67171-6_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-67170-9
Online ISBN: 978-3-030-67171-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)